Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.
Upon his return to the United States Presidency, Donald Trump signed a number of executive orders that will not have an immediate impact, but will take effect in the coming weeks.
Al Jazeera on MSN2h
Fact check: Can Trump really erase Biden’s ‘health legacy’?Trump’s early health moves suggest he aims to dismantle Biden’s drug cost and insurance expansions. What’s next?
KFF Health News on MSN18h
Trump’s early health moves signal intent to erase Biden’s legacy. What’s next is unclearPresident Donald Trump issued a flurry of executive orders and other actions on health care soon after reentering office. Other than signaling he intends to reverse many of Joe Biden’s moves, the orders will have little immediate impact.
· 1d · on MSN
Trump Order Walks Back Biden-Era Effort To Lower Prescription Drug Prices. Here's Context
Trump’s prescription drug executive order rollback didn’t quash all Biden-backed cost savings
The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.
· 1d
Trump pulls back Biden drug pricing action
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to negotiate, but if they don’t, they face fines or the possible end of Medicare reimbursements.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
President Donald Trump began his second administration with a blitz of policy actions to reorient U.S. government priorities.
The White House told federal agencies to detail by Friday a list of federal employees who are on probationary status and make recommendations on whether they should remain on the job.
Biden spent like no president in history, and, with a sleight of hand, by taking hundreds of billions out of Medicare and spending it on green energy subsidies.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Inflation was a top issue that helped propel Donald Trump back into the White House. But actions the new president has taken in his first days on the job could hit Americans - particularly seniors - in the wallet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback